SACCARDI, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.319
EU - Europa 707
AS - Asia 262
Totale 2.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.319
IE - Irlanda 199
IT - Italia 161
SE - Svezia 156
HK - Hong Kong 94
PL - Polonia 88
CN - Cina 74
JO - Giordania 41
CH - Svizzera 35
IR - Iran 21
GB - Regno Unito 13
SG - Singapore 13
RU - Federazione Russa 12
FI - Finlandia 10
IN - India 9
ES - Italia 8
DE - Germania 7
FR - Francia 7
UA - Ucraina 5
BE - Belgio 4
TR - Turchia 4
VN - Vietnam 4
KR - Corea 2
NL - Olanda 2
Totale 2.288
Salva come PNG Salva come JPEG
Città #
Dublin 199
Fairfield 188
Chandler 184
Ashburn 109
Warsaw 88
Woodbridge 83
Altamura 71
Lawrence 71
Cambridge 69
Seattle 65
Hong Kong 64
Wilmington 64
Houston 56
Ann Arbor 47
Princeton 41
Beijing 38
Florence 36
Bern 35
Boston 33
Buffalo 28
Milan 20
Dearborn 19
New York 19
Medford 14
San Diego 12
Shanghai 11
Moscow 10
Boardman 9
Barcelona 8
Falls Church 8
Norwalk 7
Singapore 6
Jacksonville 5
Pune 5
Tehran 5
Andover 4
Brussels 4
Dong Ket 4
West Jordan 4
Fuzhou 3
Guangzhou 3
Hillsboro 3
Kunming 3
Los Angeles 3
Bremen 2
Hangzhou 2
Istanbul 2
Izmir 2
Jinan 2
Kemerovo 2
Kilburn 2
Lappeenranta 2
Legnaro 2
Lyon 2
Nanchang 2
Nanjing 2
Redmond 2
Rome 2
Taranto 2
Zibello 2
Amsterdam 1
Arezzo 1
Bangalore 1
Castelliri 1
Chennai 1
Frankfurt am Main 1
Hefei 1
Heinrichsthal 1
London 1
Merate 1
Montespertoli 1
Nembro 1
Olbia 1
Old Bridge 1
Paris 1
Phoenix 1
Pisa 1
Prato 1
San Mateo 1
Seoul 1
Shenzhen 1
Washington 1
Wuhan 1
Zhengzhou 1
Totale 1.814
Salva come PNG Salva come JPEG
Nome #
A non-traditional approach to cryopreservation by ultra-rapid cooling for human mesenchymal stem cells 145
Bio-Engineered Mesenchymal Stromal Cell (MSCs) Grafts for Skin Repair/Regeneration. Preclinical Aspects 122
Therapeutic efficacy of autologous non-mobilized enriched circulating endothelial progenitors in patients with critical limb ischemia ― The scelta trial 117
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies 105
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 95
MSCs seeded on bioengineered scaffolds improve skin wound healing in rats. 86
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 81
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience 77
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients 76
The effects of Exendin-4 on bone marrow-derived mesenchymal cells. 74
Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single-centre preliminary experience 72
Human mesenchymal stromal cells preserve their stem features better when cultured in the Dulbecco's modified Eagle medium. 68
Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model. 63
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 55
Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial 51
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 50
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 46
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation 44
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 43
Mesenchymal Stem Cells and Autoimmune Diseases: The Case of Multiple Sclerosis 43
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection 42
Neuropsychological assessment in aggressive multiple sclerosis treated with stem cell transplantation 40
Management of viral reactivation in multiple sclerosis patients after autologous transplantation with BEAM/ATG conditioning regimen 40
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. 40
CMV and EBV reactivation in autologous haemopoietic stem cell transplantation for severe multiple sclerosis 39
Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis 38
HSCT for severe multiple sclerosis with BEAM/ATG: impact on female fertility 38
Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis 37
Long term follow-up of autologous stem cell transplantation (HSCT) for the treatment of secondary progressive multiple sclerosis: single centre experience 36
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 36
Comparing human bone marrow mesenchymal stem cells isolated from MS patients with ND ones: possible impact on MS therapy and immunopathology 35
Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor 35
DIFFERENCES IN MSCS IP-10 PRODUCTION BETWEEN MS PATIENTS AND HEALTHY DONORS 34
Safety profile of autologous haematopoietic stem cell transplantation following natalizumab therapy in aggressive forms of multiple sclerosis 32
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 32
Purely myeloablative conditioning regimen in aggressive multiple sclerosis: two case reports 32
Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience 31
GENE EXPRESSION ANALYSIS OF PBMNC FROM MS PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION (HSCT) 30
5-methyltetrahydrofolate (mTHF) induces monocytes differentiation in HL60 cells 29
intermediate intensity regimen in autologous HSCT for severe Multiple Sclerosis: a a large, single center experience 29
Preliminary results of ASTIMS, a prospective randomised Phase II EBMT trial on autologous HSCT in poor prognosis Multiple Sclerosis 29
Long term outcomes after autologous hematopoietic stem cell transplantation for treatment of MS 26
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications 20
Impact of autologous haematopoietic stem cell transplantation on fertility in aggressive multiple sclerosis 20
Panel Session Report: Multiple Sclerosis 20
Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update 12
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis 10
Should autologous hematopoietic stem cell transplantation be offered as a first-line disease modifying therapy to patients with multiple sclerosis? 8
Totale 2.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201979 0 0 0 0 0 0 0 0 0 0 39 40
2019/2020430 20 20 3 21 60 64 56 47 37 41 42 19
2020/2021241 27 24 8 35 22 16 13 14 22 36 15 9
2021/2022272 3 32 12 23 17 4 8 29 15 6 42 81
2022/2023891 55 197 61 35 60 140 115 61 90 0 35 42
2023/2024387 10 60 49 31 38 57 22 83 9 27 1 0
Totale 2.363